Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cancer vaccine
Biotech
Transgene's viral cancer vaccine flunks midphase test
The biotech is analyzing aspects of the data including a “positive efficacy trend” in a prespecified subgroup before deciding on its next steps.
Nick Paul Taylor
Oct 14, 2024 4:59am
Gritstone files for bankruptcy in hope of keeping R&D afloat
Oct 10, 2024 6:36am
Cash-strapped Gritstone starts search for strategic alternatives
Oct 1, 2024 10:07am
ESMO: Cancer vaccine and Keytruda deliver in phase 2 trial
Sep 14, 2024 2:30am
Ultimovacs cancer vaccine fails again, enters last chance saloon
Aug 6, 2024 4:14am
BioNTech, Regeneron rack up response rate win for cancer vaccine
Jul 30, 2024 6:45am
